JSPRJasper Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Jasper Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JSPR본 종목 | $18M#7 | — | 5.2x#9 | — | — | 100.0%#1 | — | -0.0%#1 | — | — | -78.7%#10 | — |
| ESLA | $32M#2 | — | — | — | — | -78.7%#13 | — | — | — | — | -15.3%#1 | — |
| TVGN | $31M#3 | — | — | — | — | -91.4%#14 | — | — | — | — | -85.6%#13 | — |
| ALGS | — | — | — | — | -39.5%#3 | 81.6%#2 | -4024.9%#2 | -76.1%#5 | — | — | -41.2%#5 | — |
| GRMLW | $25M#4 | — | 0.5x#4 | — | — | -71.6%#11 | — | -20.5%#2 | -17.1%#1 | — | -21.7%#3 | — |
| GRML | $23M#5 | — | 0.5x#3 | — | — | -71.6%#11 | — | -20.5%#2 | -17.1%#1 | — | -80.7%#11 | — |
| ENGNW | $22M#6 | 0.1x#1 | 0.1x#1 | — | — | -112.7%#15 | — | -46.0%#4 | — | — | -57.3%#7 | — |
| CLDI | $36M#1 | — | 7.3x#10 | 798.2x#4 | — | 10.1%#7 | -44977.8%#4 | -403.4%#10 | — | — | -98.4%#14 | — |
| PLUR | $17M#8 | — | — | 12.5x#1 | 309.8%#1 | 8.9%#8 | -1659.9%#1 | — | — | — | -71.0%#8 | — |
| PASG | $15M#9 | — | 1.3x#6 | — | — | 29.7%#4 | — | -387.4%#9 | — | — | -17.5%#2 | — |
| BCLI | $13M#10 | — | — | — | — | 11.3%#6 | — | — | — | — | — | — |
| SNTI | $12M#11 | — | 4.7x#8 | 544.0x#3 | — | -16.4%#10 | -312631.8%#5 | -2395.2%#11 | — | — | -77.4%#9 | — |
| CVM | $12M#12 | — | 1.7x#7 | 44.1x#2 | 65.5%#2 | 5.6%#9 | -9396.5%#3 | -369.6%#8 | — | — | -85.2%#12 | — |
| INTS | $12M#13 | — | 1.2x#5 | — | — | 28.7%#5 | — | -116.3%#7 | — | — | -30.4%#4 | — |
| INAB | $9M#14 | — | 0.4x#2 | — | — | 36.1%#3 | — | -85.3%#6 | — | — | -54.5%#6 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice